Recombinant multi-species CD2BP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CD2BP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a bi-functional protein. In the cytoplasm, the encoded protein binds the cytoplasmic tail of human surface antigen CD2 via its C-terminal GYF domain, and regulate CD2-triggered T lymphocyte activation. In the nucleus, this protein is a component of the U5 small nuclear ribonucleoprotein complex and is involved in RNA splicing. A pseudogene has been identified on chromosome 7. Alternative splicing results in multiple transcript variants but their biological validity has not been determined. [provided by RefSeq, Nov 2008]
The Alternative Names of target: 1500011B02Rik,2410024K20Rik,CD2 antigen cytoplasmic tail-binding protein 2,CD2 cytoplasmic domain-binding protein 2,CD2 tail-binding protein 2,CD2BP2,Cd2bp2,FWP010,LIN1,PPP1R59,Snu40,U5 snRNP 52K protein (U5-52K),U5-52K

Target products collectionGo to CD2BP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP3507-Ag-1/ GM-Tg-hg-IP3507-Ag-2 Human CD2BP2 protein Human
GM-Tg-rg-IP3507-Ag-1/ GM-Tg-rg-IP3507-Ag-2 Rat CD2BP2 protein Rat
GM-Tg-mg-IP3507-Ag-1/ GM-Tg-mg-IP3507-Ag-2 Mouse CD2BP2 protein Mouse
GM-Tg-cynog-IP3507-Ag-1/ GM-Tg-cynog-IP3507-Ag-2 Cynomolgus/Rhesus macaque CD2BP2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP3507-Ag-1/ GM-Tg-felg-IP3507-Ag-2 Feline CD2BP2 protein Feline
GM-Tg-cang-IP3507-Ag-1/ GM-Tg-cang-IP3507-Ag-2 Canine CD2BP2 protein Canine
GM-Tg-bovg-IP3507-Ag-1/ GM-Tg-bovg-IP3507-Ag-2 Bovine CD2BP2 protein Bovine
GM-Tg-equg-IP3507-Ag-1/ GM-Tg-equg-IP3507-Ag-2 Equine CD2BP2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP3507-Ag-1/ GM-Tg-hg-IP3507-Ag-2; GM-Tg-rg-IP3507-Ag-1/ GM-Tg-rg-IP3507-Ag-2;
GM-Tg-mg-IP3507-Ag-1/ GM-Tg-mg-IP3507-Ag-2; GM-Tg-cynog-IP3507-Ag-1/ GM-Tg-cynog-IP3507-Ag-2;
GM-Tg-felg-IP3507-Ag-1/ GM-Tg-felg-IP3507-Ag-2; GM-Tg-cang-IP3507-Ag-1/ GM-Tg-cang-IP3507-Ag-2;
GM-Tg-bovg-IP3507-Ag-1/ GM-Tg-bovg-IP3507-Ag-2; GM-Tg-equg-IP3507-Ag-1/ GM-Tg-equg-IP3507-Ag-2
Products Name CD2BP2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CD2BP2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CD2BP2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.